Myalept OverviewMetreleptin (trade names Myalept, Myalepta) is a synthetic analog of the hormone leptin used to treat diabetes and various forms of dyslipidemia. It has been approved in Japan for metabolic disorders including lipodystrophy and in the United States as replacement therapy to treat the complications of leptin deficiency, in addition to diet, in patients with congenital generalized or acquired generalized lipodystrophy. In Europe based on EMA, metreleptin should be used in a...
Read more Myalept Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Metreleptin
Recent Myalept Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Injection: 11.3mg
NDC Database Records for Myalept: (2 results)Sorted by National Drug Code
- 66780-310 Myalept 11.3 mg/2.2ml Subcutaneous Injection, Powder, Lyophilized, for Solution by Amylin Pharmaceuticals, LLC
- 76431-210 Myalept 11.3 mg/2.2ml Subcutaneous Injection, Powder, Lyophilized, for Solution by Aegerion Pharmaceuticals, Inc.